Chamber and committees

The consequentials form part of the savings package of over £500 million set out to the Finance and Public Administration Committee on September 7 th . As stated in the letter, savings have been utilised to meet increased costs as a result of inflationary pressures, increase help for those hit hardest by the cost of living crisis and to fund enhanced pay settlements.

The Lyme disease vaccine candidate VLA15 was developed in Austria and, as such, is not directly supported by Scottish funding. The Scottish Government is however regarded as preferred customers for Valneva, and should the decision be taken to procure Lyme Disease vaccines from Valneva, the Scottish Government will receive preferential access and pricing. This is in recognition of the support provided to Valneva by Scotland.

Scottish Enterprise have supported Valneva Livingston with funding packages for the following vaccines, all of which have received grant support:

• Japanese Encephalitis
• Zika
• Chikungya
• Covid-19

Non-NHS provider figures relate to patients treated in non-NHS locations such as private hospitals, hospices, nursing homes, and care homes. Patients who receive treatment at a private (independent) hospital which is paid for by the NHS board should be recorded within the SMR by the relevant NHS board.

The following table presents the procedure information that has been supplied to Public Health Scotland (PHS).

Table 1: The number of procedures performed by Non-NHS Providers.

I have a weekly portfolio meeting, usually held on a Monday, with officials and clinical advisers, including the Chief Medical Officer, during which any updates regarding the monkeypox outbreak in Scotland have been, and will continue to be, discussed.

As outlined in the answer to S6W-10089, the Cabinet Secretary for Health and Social Care attends regular meetings with his counterparts in the UK and other Devolved Administrations to ensure that the Scottish Government is represented in relation to public health incidents which require a coordinated 4 Nations response. The last meeting of the UK Health Ministers Forum was on 16 June 2022. The UK Health Ministers Forum has now been replaced by an Inter-Ministerial Group meeting which is expected to meet for the first time in mid-October.

The contract notice with Corporate Travel Management (North) Ltd, was published on 9 August 2022. The contract is to source and provide travel-related services for displaced people from Ukraine including accommodation in hotels and on the M/S Victoria I and M/S Ambition.

The full contract has a value of up to £100 million with a start date of 8 July 2022 and an end date of 12 December 2024. Both the M/S Victoria and the M/S Ambition have been initially chartered for a period of 6 months.

The Scottish Government provides funding to Advice Direct Scotland to deliver telephone and digital advice services including debt and consumer advice. Spend on external consultants is an operational matter and I direct the member to Advice Direct Scotland’s website or to their Chief Executive Officer for this information.

Throughout the pandemic, NHS Boards have ensured that urgent, maternity and vital cancer services continue as usual.

Any arrangements for NHS patients to be treated at an Independent Sector hospital would need to be made between the patient and the NHS Board prior to the treatment being carried out.

Project Neptune was published on 8 September 2022 and can be accessed:

https://www.transport.gov.scot/publication/strategic-framework-of-options-for-the-chfs-network-project-neptune/

The following table provides a breakdown of the core activity undertaken at the National Eye Centre at NHS Golden Jubilee, by month, since it opened in November 2020 up to the end of June 2022.

This does not include activity undertaken in main theatres at the NHS Golden Jubilee University National Hospital in 2020-21 prior to the National Eye Centre opening, nor any activity carried out in the National Eye Centre as part of the current independent sector contracts.

We are committed to become a world leading, innovation nation, which will help us grow our economy and create sustainable, green jobs. As the recent figures from the UK Innovation Survey show, there is still work to be done.

That is why this year we will publish new innovation strategy which will ensure that our businesses, people and institutions are ready to meet the global economic challenges and opportunities we face over the next 10 years.

The Strategy will build on the support already available to businesses through our Enterprise Agencies, who since 2017 have distributed around £600m directly to businesses to build their capacity and capability to innovate, and initiatives such as the Digital Development Grant, which since September 2020 has invested almost £50m to over 5,600 SMEs to help them utilise digital technologies and enhance workforce skills.

Since 2007 Scotland’s business R&D expenditure has doubled, whereas the comparable figure for the UK as a whole was only 29% growth over the same period.

We recently commissioned The Scottish Council for Development and Industry to undertake research on the specific barriers to innovation faced by Scottish businesses. The findings from the report, together with our engagement with industry and key stakeholders, will inform a reformed package of support within the Strategy to ensure our businesses realise their innovative potential.